SCHEMBL9945018

SCHEMBL9945018

Cc1ccc(NC(=O)c2cc(N)c(NCC(C)(C)O)cc2N2CCC(C)CC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
HPGD P15428 3/20 0.41
LMNA P02545 4/20 0.41
POLB P06746 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
ITGA4 P13612 1/20 0.41
MITF O75030 1/20 0.41
HSP90AA1 P07900 1/20 0.41
G6PD P11413 1/20 0.41
PKM P14618 1/20 0.41
MC4R P32245 1/20 0.41
OPRK1 P41145 1/20 0.41
CCR6 P51684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944801 0.88 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ACYP2C9CYP2C19
SCHEMBL9945022 0.86 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ACYP2C9CYP2C19
SCHEMBL9945017 0.85 KMT2A (0.51) ALDH1A1MEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL9945016 0.82 NPC1 (0.39) ALDH1A1HPGDPOLBNPSR1GAA
SCHEMBL9946643 0.80 PTGES (0.49) LMNAMAPT
SCHEMBL9945036 0.78 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ACYP2C9CYP2C19
SCHEMBL9944763 0.78 ALDH1A1 (0.40) ALDH1A1MEN1KMT2ACYP2C9CYP2C19
SCHEMBL9898727 0.76 PTGES (0.49) ALDH1A1L3MBTL1LMNAPOLBNPSR1
SCHEMBL9944973 0.75 GAA (0.46) ALDH1A1MEN1KMT2ACYP2C9CYP2C19
SCHEMBL9944977 0.75 L3MBTL1 (0.41) ALDH1A1MEN1KMT2ACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885MEN1 4598/4885KMT2A 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.